Loading…

Ras inhibition amplifies cisplatin sensitivity of human glioblastoma

Resistance to chemotherapy is a common feature of malignant gliomas. This resistance is mediated by receptor tyrosine kinase (RTK)-regulated signaling. p21-Ras protein is pivotal in the propagation of the signal originated from many RTKs. Our aim was to investigate whether inhibition of Ras pathway...

Full description

Saved in:
Bibliographic Details
Published in:Biochemical and biophysical research communications 2004-07, Vol.320 (2), p.493-500
Main Authors: Messina, Samantha, Leonetti, Carlo, De Gregorio, Giorgia, Affatigato, Valentina, Ragona, Giuseppe, Frati, Luigi, Zupi, Gabriella, Santoni, Angela, Porcellini, Antonio
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c383t-be51cf89bf32ac6cf031c0b9c874a069982c7d5dd4804e1db5651194f5094a173
cites cdi_FETCH-LOGICAL-c383t-be51cf89bf32ac6cf031c0b9c874a069982c7d5dd4804e1db5651194f5094a173
container_end_page 500
container_issue 2
container_start_page 493
container_title Biochemical and biophysical research communications
container_volume 320
creator Messina, Samantha
Leonetti, Carlo
De Gregorio, Giorgia
Affatigato, Valentina
Ragona, Giuseppe
Frati, Luigi
Zupi, Gabriella
Santoni, Angela
Porcellini, Antonio
description Resistance to chemotherapy is a common feature of malignant gliomas. This resistance is mediated by receptor tyrosine kinase (RTK)-regulated signaling. p21-Ras protein is pivotal in the propagation of the signal originated from many RTKs. Our aim was to investigate whether inhibition of Ras pathway affects the response to cisplatin in malignant gliomas. We found an enhanced sensitivity to cisplatin of two glioblastoma cell lines expressing dominant negative Ras. Moreover, DN-Ras expressing cells, implanted in nude mice, resulted in being extremely sensitive to cisplatin. The growth of all the tumors was significantly inhibited by combining DN-Ras adenovirus infection with cisplatin treatment. The majority of glioma cells expressing DN-Ras underwent apoptosis in response to cisplatin. In vivo, DN-Ras alone did not influence the growth of tumors, suggesting that the effects of Ras-inhibition observed in vitro could not be extrapolated in vivo. The survival signal pathway transduced by Ras was essentially mediated by inhibition of caspase-9 cleavage via PI3K/Akt.
doi_str_mv 10.1016/j.bbrc.2004.06.003
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66657754</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006291X04012306</els_id><sourcerecordid>66657754</sourcerecordid><originalsourceid>FETCH-LOGICAL-c383t-be51cf89bf32ac6cf031c0b9c874a069982c7d5dd4804e1db5651194f5094a173</originalsourceid><addsrcrecordid>eNqFkM1LwzAYh4Mobk7_AQ_Sk7fW922TtAEvMj9hIIiCt5Ckqcvox0zawf57Ozbwpqf38D6_5_AQcomQICC_WSVae5OkADQBngBkR2SKICBOEegxmQIAj1OBnxNyFsIKAJFycUomyFIUBeNTcv-mQuTapdOud10bqWZdu8rZEBkX1rXqXRsF24bxu3H9NuqqaDk0qo2-atfpWoW-a9Q5OalUHezF4c7Ix-PD-_w5Xrw-vczvFrHJiqyPtWVoqkLoKkuV4aaCDA1oYYqcKuBCFKnJS1aWtABqsdSMM0RBKwaCKsyzGbnee9e--x5s6GXjgrF1rVrbDUFyzlmeM_oviCLnvKDpCKZ70PguBG8rufauUX4rEeQuslzJXWS5iyyByzHyOLo62Afd2PJ3cqg6Ard7wI4xNs56GYyzrbGl89b0suzcX_4fdEqNuQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19766842</pqid></control><display><type>article</type><title>Ras inhibition amplifies cisplatin sensitivity of human glioblastoma</title><source>Elsevier</source><creator>Messina, Samantha ; Leonetti, Carlo ; De Gregorio, Giorgia ; Affatigato, Valentina ; Ragona, Giuseppe ; Frati, Luigi ; Zupi, Gabriella ; Santoni, Angela ; Porcellini, Antonio</creator><creatorcontrib>Messina, Samantha ; Leonetti, Carlo ; De Gregorio, Giorgia ; Affatigato, Valentina ; Ragona, Giuseppe ; Frati, Luigi ; Zupi, Gabriella ; Santoni, Angela ; Porcellini, Antonio</creatorcontrib><description>Resistance to chemotherapy is a common feature of malignant gliomas. This resistance is mediated by receptor tyrosine kinase (RTK)-regulated signaling. p21-Ras protein is pivotal in the propagation of the signal originated from many RTKs. Our aim was to investigate whether inhibition of Ras pathway affects the response to cisplatin in malignant gliomas. We found an enhanced sensitivity to cisplatin of two glioblastoma cell lines expressing dominant negative Ras. Moreover, DN-Ras expressing cells, implanted in nude mice, resulted in being extremely sensitive to cisplatin. The growth of all the tumors was significantly inhibited by combining DN-Ras adenovirus infection with cisplatin treatment. The majority of glioma cells expressing DN-Ras underwent apoptosis in response to cisplatin. In vivo, DN-Ras alone did not influence the growth of tumors, suggesting that the effects of Ras-inhibition observed in vitro could not be extrapolated in vivo. The survival signal pathway transduced by Ras was essentially mediated by inhibition of caspase-9 cleavage via PI3K/Akt.</description><identifier>ISSN: 0006-291X</identifier><identifier>EISSN: 1090-2104</identifier><identifier>DOI: 10.1016/j.bbrc.2004.06.003</identifier><identifier>PMID: 15219856</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adenoviridae - genetics ; Adenovirus ; Animals ; Antineoplastic Agents - pharmacology ; Apoptosis ; Brain Neoplasms - pathology ; Cell Line, Tumor ; Chemotherapy ; Cisplatin - pharmacology ; Drug resistance ; Enzyme Activation ; Gene therapy ; Glioblastoma ; Glioblastoma - pathology ; Humans ; Male ; Mice ; Mice, Nude ; Neoplasm Transplantation ; Phosphatidylinositol 3-Kinases - metabolism ; Protein-Serine-Threonine Kinases - metabolism ; Proto-Oncogene Proteins - metabolism ; Proto-Oncogene Proteins c-akt ; Ras ; ras Proteins - antagonists &amp; inhibitors ; ras Proteins - genetics ; Signal transduction</subject><ispartof>Biochemical and biophysical research communications, 2004-07, Vol.320 (2), p.493-500</ispartof><rights>2004 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c383t-be51cf89bf32ac6cf031c0b9c874a069982c7d5dd4804e1db5651194f5094a173</citedby><cites>FETCH-LOGICAL-c383t-be51cf89bf32ac6cf031c0b9c874a069982c7d5dd4804e1db5651194f5094a173</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15219856$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Messina, Samantha</creatorcontrib><creatorcontrib>Leonetti, Carlo</creatorcontrib><creatorcontrib>De Gregorio, Giorgia</creatorcontrib><creatorcontrib>Affatigato, Valentina</creatorcontrib><creatorcontrib>Ragona, Giuseppe</creatorcontrib><creatorcontrib>Frati, Luigi</creatorcontrib><creatorcontrib>Zupi, Gabriella</creatorcontrib><creatorcontrib>Santoni, Angela</creatorcontrib><creatorcontrib>Porcellini, Antonio</creatorcontrib><title>Ras inhibition amplifies cisplatin sensitivity of human glioblastoma</title><title>Biochemical and biophysical research communications</title><addtitle>Biochem Biophys Res Commun</addtitle><description>Resistance to chemotherapy is a common feature of malignant gliomas. This resistance is mediated by receptor tyrosine kinase (RTK)-regulated signaling. p21-Ras protein is pivotal in the propagation of the signal originated from many RTKs. Our aim was to investigate whether inhibition of Ras pathway affects the response to cisplatin in malignant gliomas. We found an enhanced sensitivity to cisplatin of two glioblastoma cell lines expressing dominant negative Ras. Moreover, DN-Ras expressing cells, implanted in nude mice, resulted in being extremely sensitive to cisplatin. The growth of all the tumors was significantly inhibited by combining DN-Ras adenovirus infection with cisplatin treatment. The majority of glioma cells expressing DN-Ras underwent apoptosis in response to cisplatin. In vivo, DN-Ras alone did not influence the growth of tumors, suggesting that the effects of Ras-inhibition observed in vitro could not be extrapolated in vivo. The survival signal pathway transduced by Ras was essentially mediated by inhibition of caspase-9 cleavage via PI3K/Akt.</description><subject>Adenoviridae - genetics</subject><subject>Adenovirus</subject><subject>Animals</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Apoptosis</subject><subject>Brain Neoplasms - pathology</subject><subject>Cell Line, Tumor</subject><subject>Chemotherapy</subject><subject>Cisplatin - pharmacology</subject><subject>Drug resistance</subject><subject>Enzyme Activation</subject><subject>Gene therapy</subject><subject>Glioblastoma</subject><subject>Glioblastoma - pathology</subject><subject>Humans</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Nude</subject><subject>Neoplasm Transplantation</subject><subject>Phosphatidylinositol 3-Kinases - metabolism</subject><subject>Protein-Serine-Threonine Kinases - metabolism</subject><subject>Proto-Oncogene Proteins - metabolism</subject><subject>Proto-Oncogene Proteins c-akt</subject><subject>Ras</subject><subject>ras Proteins - antagonists &amp; inhibitors</subject><subject>ras Proteins - genetics</subject><subject>Signal transduction</subject><issn>0006-291X</issn><issn>1090-2104</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><recordid>eNqFkM1LwzAYh4Mobk7_AQ_Sk7fW922TtAEvMj9hIIiCt5Ckqcvox0zawf57Ozbwpqf38D6_5_AQcomQICC_WSVae5OkADQBngBkR2SKICBOEegxmQIAj1OBnxNyFsIKAJFycUomyFIUBeNTcv-mQuTapdOud10bqWZdu8rZEBkX1rXqXRsF24bxu3H9NuqqaDk0qo2-atfpWoW-a9Q5OalUHezF4c7Ix-PD-_w5Xrw-vczvFrHJiqyPtWVoqkLoKkuV4aaCDA1oYYqcKuBCFKnJS1aWtABqsdSMM0RBKwaCKsyzGbnee9e--x5s6GXjgrF1rVrbDUFyzlmeM_oviCLnvKDpCKZ70PguBG8rufauUX4rEeQuslzJXWS5iyyByzHyOLo62Afd2PJ3cqg6Ard7wI4xNs56GYyzrbGl89b0suzcX_4fdEqNuQ</recordid><startdate>20040723</startdate><enddate>20040723</enddate><creator>Messina, Samantha</creator><creator>Leonetti, Carlo</creator><creator>De Gregorio, Giorgia</creator><creator>Affatigato, Valentina</creator><creator>Ragona, Giuseppe</creator><creator>Frati, Luigi</creator><creator>Zupi, Gabriella</creator><creator>Santoni, Angela</creator><creator>Porcellini, Antonio</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20040723</creationdate><title>Ras inhibition amplifies cisplatin sensitivity of human glioblastoma</title><author>Messina, Samantha ; Leonetti, Carlo ; De Gregorio, Giorgia ; Affatigato, Valentina ; Ragona, Giuseppe ; Frati, Luigi ; Zupi, Gabriella ; Santoni, Angela ; Porcellini, Antonio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c383t-be51cf89bf32ac6cf031c0b9c874a069982c7d5dd4804e1db5651194f5094a173</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adenoviridae - genetics</topic><topic>Adenovirus</topic><topic>Animals</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Apoptosis</topic><topic>Brain Neoplasms - pathology</topic><topic>Cell Line, Tumor</topic><topic>Chemotherapy</topic><topic>Cisplatin - pharmacology</topic><topic>Drug resistance</topic><topic>Enzyme Activation</topic><topic>Gene therapy</topic><topic>Glioblastoma</topic><topic>Glioblastoma - pathology</topic><topic>Humans</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Nude</topic><topic>Neoplasm Transplantation</topic><topic>Phosphatidylinositol 3-Kinases - metabolism</topic><topic>Protein-Serine-Threonine Kinases - metabolism</topic><topic>Proto-Oncogene Proteins - metabolism</topic><topic>Proto-Oncogene Proteins c-akt</topic><topic>Ras</topic><topic>ras Proteins - antagonists &amp; inhibitors</topic><topic>ras Proteins - genetics</topic><topic>Signal transduction</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Messina, Samantha</creatorcontrib><creatorcontrib>Leonetti, Carlo</creatorcontrib><creatorcontrib>De Gregorio, Giorgia</creatorcontrib><creatorcontrib>Affatigato, Valentina</creatorcontrib><creatorcontrib>Ragona, Giuseppe</creatorcontrib><creatorcontrib>Frati, Luigi</creatorcontrib><creatorcontrib>Zupi, Gabriella</creatorcontrib><creatorcontrib>Santoni, Angela</creatorcontrib><creatorcontrib>Porcellini, Antonio</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Biochemical and biophysical research communications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Messina, Samantha</au><au>Leonetti, Carlo</au><au>De Gregorio, Giorgia</au><au>Affatigato, Valentina</au><au>Ragona, Giuseppe</au><au>Frati, Luigi</au><au>Zupi, Gabriella</au><au>Santoni, Angela</au><au>Porcellini, Antonio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ras inhibition amplifies cisplatin sensitivity of human glioblastoma</atitle><jtitle>Biochemical and biophysical research communications</jtitle><addtitle>Biochem Biophys Res Commun</addtitle><date>2004-07-23</date><risdate>2004</risdate><volume>320</volume><issue>2</issue><spage>493</spage><epage>500</epage><pages>493-500</pages><issn>0006-291X</issn><eissn>1090-2104</eissn><abstract>Resistance to chemotherapy is a common feature of malignant gliomas. This resistance is mediated by receptor tyrosine kinase (RTK)-regulated signaling. p21-Ras protein is pivotal in the propagation of the signal originated from many RTKs. Our aim was to investigate whether inhibition of Ras pathway affects the response to cisplatin in malignant gliomas. We found an enhanced sensitivity to cisplatin of two glioblastoma cell lines expressing dominant negative Ras. Moreover, DN-Ras expressing cells, implanted in nude mice, resulted in being extremely sensitive to cisplatin. The growth of all the tumors was significantly inhibited by combining DN-Ras adenovirus infection with cisplatin treatment. The majority of glioma cells expressing DN-Ras underwent apoptosis in response to cisplatin. In vivo, DN-Ras alone did not influence the growth of tumors, suggesting that the effects of Ras-inhibition observed in vitro could not be extrapolated in vivo. The survival signal pathway transduced by Ras was essentially mediated by inhibition of caspase-9 cleavage via PI3K/Akt.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>15219856</pmid><doi>10.1016/j.bbrc.2004.06.003</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-291X
ispartof Biochemical and biophysical research communications, 2004-07, Vol.320 (2), p.493-500
issn 0006-291X
1090-2104
language eng
recordid cdi_proquest_miscellaneous_66657754
source Elsevier
subjects Adenoviridae - genetics
Adenovirus
Animals
Antineoplastic Agents - pharmacology
Apoptosis
Brain Neoplasms - pathology
Cell Line, Tumor
Chemotherapy
Cisplatin - pharmacology
Drug resistance
Enzyme Activation
Gene therapy
Glioblastoma
Glioblastoma - pathology
Humans
Male
Mice
Mice, Nude
Neoplasm Transplantation
Phosphatidylinositol 3-Kinases - metabolism
Protein-Serine-Threonine Kinases - metabolism
Proto-Oncogene Proteins - metabolism
Proto-Oncogene Proteins c-akt
Ras
ras Proteins - antagonists & inhibitors
ras Proteins - genetics
Signal transduction
title Ras inhibition amplifies cisplatin sensitivity of human glioblastoma
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T22%3A51%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ras%20inhibition%20amplifies%20cisplatin%20sensitivity%20of%20human%20glioblastoma&rft.jtitle=Biochemical%20and%20biophysical%20research%20communications&rft.au=Messina,%20Samantha&rft.date=2004-07-23&rft.volume=320&rft.issue=2&rft.spage=493&rft.epage=500&rft.pages=493-500&rft.issn=0006-291X&rft.eissn=1090-2104&rft_id=info:doi/10.1016/j.bbrc.2004.06.003&rft_dat=%3Cproquest_cross%3E66657754%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c383t-be51cf89bf32ac6cf031c0b9c874a069982c7d5dd4804e1db5651194f5094a173%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=19766842&rft_id=info:pmid/15219856&rfr_iscdi=true